تقرير
Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
| العنوان: | Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma |
|---|---|
| المساهمون: | Beth Christian, Principal Investigator |
| المصدر: | Cohen JB, WeL, Maddocks KJ, Chrtn B, Heffner LT, Langston AA, Lechowz MJ, Porcu P, Flowers CR, Deve SM, Blum KA. Gemcabe and bendamuste a safe and effecte salvage regen for patnts wh recurrent/refractory Hodgk lymphoma: Results of a phase 1/2 study. Cancer. 2020 Mar 15;126(6):1235-1242. do 10.1002/cncr.32640. Epub 2019 Dec 10. A Phase I/II Study Of Gemcitabine And Bendamustine In Patients With Relapsed Or Refractory Hodgkin's Lymphoma |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT01535924Test |
| Other URLs: | http://cancer.osu.eduTest |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |